Work

SAT-448 A 10-week, randomized, double blind, placebo-controlled exploratory proof of concept study of Utreglutide (GL0034) in individuals with overweight and obesity

Year: 2025

Type: conference-abstract

Source: Journal of Hepatology

DOI: 10.1016/s0168-8278(25)01704-0

Authors: Rajamannar Thennati, Vinod Burade, Muthukumaran Natarajan, Pradeep Shahi, Ravishankara Nagaraja, Paolo Battisti, Thierry Duvauchelle, Bernard Thorens, Richard E Pratley, Tina Vilsbøll, Rohit Loomba

Language: English

Topic: Pharmacology and Obesity Treatment

Subfield: Pharmacology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410172723

Cites:

Cited by:

Related to: 10